Network origin in Zachary Hill first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
Soteria Biotherapeutics, Inc.
 Soteria Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Soteria Biotherapeutics, Inc. develops next-generation immunotherapies. Its development allows to control the activity of immunomodulatory therapeutics such as bi-specific T-cell engagers (BiTEs) and CAR T-cells.The company was founded by Zachary Hill and Alexander Martinko and is headquartered in San Francisco, CA.
2
| Holding Company | Pharmaceuticals: Major | 2 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Zachary Hill via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| EXELIXIS, INC. | Pharmaceuticals: Major | Director of Finance/CFO | |
KAI Pharmaceuticals, Inc.
 KAI Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology KAI Pharmaceuticals, Inc. discovers and develops biopharmaceutical drugs. It is a multiple, novel clinical-stage programs in the areas of cardiovascular, renal, and pain. The company was founded in 2002 and is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Director of Finance/CFO | |
| Babson College | College/University | Undergraduate Degree | |
| RELYPSA INC | Pharmaceuticals: Major | Director of Finance/CFO | |
| FORTY SEVEN, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ATRECA, INC. | Biotechnology | Director/Board Member | |
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. BiotechnologyHealth Technology Antiva Biosciences, Inc. is a biopharmaceutical company developing novel, topical therapeutics for the treatment of diseases caused by HPV infection. The company was founded by Karl Y. Hostetler in 2012 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Executive Officer |
Statistics
International
| United States | 9 |
| Czech Republic | 2 |
Sectoral
| Health Technology | 8 |
| Commercial Services | 2 |
| Consumer Services | 2 |
Operational
| Director of Finance/CFO | 4 |
| Director/Board Member | 4 |
| Independent Dir/Board Member | 2 |
| Chief Executive Officer | 2 |
| Chief Administrative Officer | 1 |
Most connected contacts
| Insiders | |
|---|---|
| Kristine Ball | 11 |
| Alexander Martinko | 1 |
- Stock Market
- Insiders
- Zachary Hill
- Company connections
